Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 3/20 | 0.54 |
| ▸ | ARG2 | P78540 | 2/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 10/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 10/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 10/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 9/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3676543 | 1.00 | ARG1 (0.54) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL28207275 | 1.00 | ARG1 (0.54) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| Hydrochloric Acid SCHEMBL28206792 | 0.98 | ARG1 (0.53) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31603619 | 0.89 | — | — | |
| SCHEMBL28174553 | 0.85 | ARG1 (0.53) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL30593437 | 0.81 | ARG1 (0.53) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5442859 | 0.81 | ARG1 (0.53) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL30085352 | 0.81 | ARG1 (0.53) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL1359695 | 0.81 | ARG1 (0.53) | ARG1ARG2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL1025995 | 0.81 | ARG1 (0.41) | ARG1ARG2SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250295157-A1 | METHODS FOR THE IMPROVEMENT AND MAINTENANCE OF WEIGHT LOSS | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2025-09-25 | — | — | US | disclosed |
| US-12349713-B2 | Methods for the improvement and maintenance of weight loss | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2025-07-08 | — | — | US | disclosed |
| EP-4099849-A1 | COMPOSITIONS AND METHODS FOR THE IMPROVEMENT AND MAINTENANCE OF GLUCOSE METABOLISM IN CHILDHOOD AND ADOLESCENCE | Société des Produits Nestlé S.A. (CH) | 2022-12-14 | — | — | EP | disclosed |
| US-20220369685-A1 | COMPOSITIONS AND METHODS FOR THE IMPROVEMENT AND MAINTENANCE OF GLUCOSE METABOLISM IN CHILDHOOD AND ADOLESCENCE | NESTLE SA (CH) | 2022-11-24 | — | — | US | disclosed |
| US-20220338521-A1 | COMPOSITIONS AND METHODS FOR THE IMPROVEMENT AND MAINTENANCE OF WEIGHT LOSS | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2022-10-27 | — | — | US | disclosed |
| CN-114980753-A | Compositions and methods for improving and maintaining glucose metabolism in children and adolescents | 雀巢产品有限公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-114423304-A | Compositions and methods for improvement and maintenance of weight loss | 雀巢产品有限公司 | 2022-04-29 | — | — | CN | disclosed |
| WO-2021156181-A1 | COMPOSITIONS AND METHODS FOR THE IMPROVEMENT AND MAINTENANCE OF GLUCOSE METABOLISM IN CHILDHOOD AND ADOLESCENCE | Société des Produits Nestlé S.A. (CH) | 2021-08-12 | — | — | WO | disclosed |
| EP-3197445-B1 | PROLINE OR PROLINE DERIVATIVES FOR THE TREATMENT OF DEMENTIA | SALAMA ZOSER B (DE) | 2021-04-28 | — | — | EP | disclosed |
| WO-2021058358-A1 | COMPOSITIONS AND METHODS FOR THE IMPROVEMENT AND MAINTENANCE OF WEIGHT LOSS | Société des Produits Nestlé S.A. (CH) | 2021-04-01 | — | — | WO | disclosed |
| CN-105621408-A | Method for manufacturing biomass powdered activated carbon by aid of loquat stone | LIUZHOU DONGHOU BIOENERGY TECH CO LTD | 2016-06-01 | — | — | CN | disclosed |
| WO-2016046162-A1 | PROLINE OR PROLINE DERIVATIVES FOR THE TREATMENT OF DEMENTIA | SALAMA ZOSER B (DE) | 2016-03-31 | — | — | WO | disclosed |
| CN-105168762-A | Medicament for treating stomach distension and preparation method thereof | HUO CHUANSHENG | 2015-12-23 | — | — | CN | disclosed |
| CN-104771513-A | Traditional Chinese medicine composition for treating cholecystitis | WANG YULING | 2015-07-15 | — | — | CN | disclosed |
| CN-104758622-A | Liver soothing and qi regulating preparation for patient with cholecystitis and preparation method of liver soothing and qi regulating preparation | WANG YULING | 2015-07-08 | — | — | CN | disclosed |
| US-7727530-B2 | Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody | SALAMA ZOSER B | 2010-06-01 | — | — | US | disclosed |
| CN-1997365-A | Anticancer composition containing proline or its derivative and antitumor antibody | SALAMA ZOSER B (DE) | 2007-07-11 | — | — | CN | disclosed |
| EP-1765328-A1 | ANTI-CANCER COMPOSITION COMPRISING PROLINE OR ITS DERIVATIVES AND AN ANTI-TUMOUR ANTIBODY | Salama, Zoser B. (DE) | 2007-03-28 | — | — | EP | disclosed |
| WO-2005120495-A1 | ANTI-CANCER COMPOSITION COMPRISING PROLINE OR ITS DERIVATIVES AND AN ANTI-TUMOUR ANTIBODY | SALAMA ZOSER B (DE) | 2005-12-22 | — | — | WO | disclosed |
| US-20050276810-A1 | Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody | SALAMA ZOSER B | 2005-12-15 | — | — | US | disclosed |